So far - totally satisfied. Good communication and follow-up.
John M.
6 years ago
According to Forbes.com, Lupin Pharmaceuticals Inc. has announced the recall of all its irbesartan tablets and their irbesartan plus hydrochlorothiazide (HCTZ) tablets. The recall was initiated due to the discovery of a potentially cancer-causing impurity, N-nitrosoirbesartan, in several lots of Lupin’s irbesartan plus hydrochlorothiazide (HCTZ) tablets. The recall states that the blood pressure medication was found to contain […]
Irbesartan Cancer Lawsuit
According to Forbes.com, Lupin Pharmaceuticals Inc. has announced the recall of all its irbesartan tablets and their irbesartan plus hydrochlorothiazide (HCTZ) tablets. The recall was initiated due to the discovery of a potentially cancer-causing impurity, N-nitrosoirbesartan, in several lots of Lupin’s irbesartan plus hydrochlorothiazide (HCTZ) tablets. The recall states that the blood pressure medication was found to contain unacceptably high levels of carcinogen.
N-nitrosoirbesartan has been discovered in several blood pressure medications since 2018.
Irbesartan is an ARB that widens the blood vessels causing lower blood pressure. The irbesartan plus HCTZ tablet combines a diuretic and works with different mechanisms with irbesartan. Increasing the patient’s daily urination helps to rid the body of excess salt, reducing the patient’s blood pressure.
Lupin is certainly not the only company to make and distribute irbesartan-containing products. Don’t automatically assume that your irbesartan is affected by the recall. Check your package. No, not that kind of package, but the package that the medication came in when you purchased it. Take a look at the label on the bottle as well. If you still can’t tell who made your medication, call your pharmacist. Lupin had already discontinued in January 2021 the marketing of both irbesartan alone and irbesartan plus HCTZ. Nevertheless, such tablets are still out there. Therefore, Lupin recalls all tablets that may have been shipped from October 8, 2018, to September 30, 2021.
N-nitrosoirbesartan becomes a problem for patients after they consume the chemical repeatedly over time. The recall advises patients to speak with their doctors before discontinuing irbesartan or irbesartan plus HCTZ use.
This blood pressure medication recall appears to be a trend, and the FDA needs to determine which systems need to be changed.
Were you or a loved one harmed by a N-nitrosoirbesartan contaminated medication? Parker Waichman LLP helps families recover monetary compensation for harm caused by defective medications. For your free consultation, contact our law firm today by using our live chat or calling 1-800-YOUR-LAWYER (1-800-968-7529).